Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit

GlaxoSmithKline6,139 enrolled

Overview

The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.

Study Type

OBSERVATIONAL

Enrollment

6,139

Conditions

Asthma

Interventions

Fluticasone propionate/salmeterol combination ED MDDRUG

Receipt of fluticasone propionate/salmeterol combination from the ED physician

Fluticasone propionate/salmeterol combination OP MDDRUG

Receipt of fluticasone propionate/salmeterol combination from the OP physician

Eligibility

Sex: ALLMin age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects with asthma as determined by ICD-9 codes and asthma drug use * at least 12 years of age * discharged from an initial Emergency Department visit within 12 months Exclusion Criteria: * Subjects with COPD or treatment for COPD

Outcomes

Primary Outcomes

Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event

A subsequent asthma-related inpatient (IP) visit or emergency department (ED) visit were defined as visits within 6 months of the index event. The index event was defined as an asthma-related hospitalization or ED visit occuring between 2004 and 2008.

Time frame: Data were collected during a 4-year period from January 1, 2004 to December 31, 2008.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.